Navigation Links
Duska Therapeutics Receives Comments From FDA on Phase 3 ATPace(TM) Protocol Synopsis
Date:8/12/2008

treatment of heart failure. In addition, Duska has a preclinical program to develop new chemical entities that target a newly discovered pathway in the pathophysiology of chronic obstructive pulmonary disease. For more information, visit http://www.duskatherapeutics.com.

Forward-looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended that involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. The forward-looking statements are based on current expectations, estimates and projections made by management. Duska intends for the forward-looking statements to be covered by the safe harbor provisions for forward-looking statements. Words such as "anticipates," "expects," "intends," "plans," "believes," "seeks," "estimates," or variations of such words are intended to identify such forward-looking statements. All statements in this release regarding the future outlook related to Duska are forward-looking statements, including the statements that Duska plans to submit the revised Phase 3 clinical trial to the FDA for Special Protocol Assessment (SPA) procedure approval, Duska believes that the initial dose of ATPace(TM) will be significantly more efficacious than the initial labeled dose of adenosine in terminating PSVT, ATP is believed to have dual inhibitory action; one mediated by adenosine, the product of its rapid enzymatic degradation, and the other, a triggered vagal reflex, Duska intends to initiate a single, prospective, placebo-controlled, and randomized trial in patients presenting to the emergency room with PSVT to demonstrate ATPace's clinical safety and efficacy, Duska intends to file a New Drug Application under section 505(b)(2), Dr. Amir Pelleg believes that the comments of
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Duska Therapeutics Plans 505(b)(2) NDA Filing Route for ATPace(TM)
2. Duska Therapeutics Sponsored University of Pennsylvania Study Demonstrates ATP Improves Sperm Motility and In Vitro Fertilization in Animals
3. Prime Therapeutics Receives TIPPS Certification
4. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
5. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
6. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
7. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
8. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
9. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
10. Prime Therapeutics Announces URAC Accreditation
11. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... (PRWEB) September 18, 2014 It is that ... in health and wellness. Once again, Evensong Spa ... Week by offering three services at a special $50 rate ... managed by Marcus Hotels & Resorts , is the ... event encouraging Americans to embrace health and wellness by experiencing ...
(Date:9/18/2014)... Study after study has proven it true: exercise is ... Pennsylvania scientists suggests that exercise may have an added ... performed in a mouse model of melanoma, found that ... alone. , Joseph Libonati, an associate professor in ... of Innovative and Translational Nursing Research, was the senior ...
(Date:9/18/2014)... Lake City, UT (PRWEB) September 18, 2014 ... North America will be recognizing their shared fundraising impact ... on Thursday, Sept. 25. , The first-ever Dance Marathon ... more than $20 million projected to be raised by ... their community’s CMN Hospital. Donations generated through Dance Marathon ...
(Date:9/18/2014)... breeding grounds for microbes -- don,t worry, it,s a ... years, not all microbes are bad. Many active enzymes ... beneficial to humans as an important part of our ... , Candida albicans , an opportunistic yeast pathogen ... doesn,t damage our healthy personal ecosystem. However, when our ...
(Date:9/18/2014)... National Institutes of Health (NIH) recently awarded the first ... to the Los Angeles Biomedical Research Institute (LA BioMed) ... vaccine to protect patients from the healthcare-related infections, ... (MRSA). , The National Institute of Allergy and Infectious ... LA BioMed infectious disease specialists John E. Edwards, MD, ...
Breaking Medicine News(10 mins):Health News:Evensong Spa Celebrates Spa Week with $50 Services 2Health News:Evensong Spa Celebrates Spa Week with $50 Services 3Health News:Exercise boosts tumor-fighting ability of chemotherapy, Penn team finds 2Health News:250 Campuses Usher in School Year of Saving Kids’ Lives During First-Ever “Dance Marathon Day” on Sept. 25 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 2Health News:Everything in moderation: Micro-8 to study regulating pathogens in space 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2
... law stipulates that the Department of Veterans Affairs has ... have earned by virtue of their service to our ... of Vietnam Veterans of America (VVA). "What is ... inform veterans -- and the healthcare community -- of ...
... N.J., May 19 Quest Diagnostics Incorporated (NYSE: ... and services, announced today that it has commenced a cash ... amount (the "Tender Cap") of its 5.125% Senior Notes due ... The terms and conditions of the tender offer are described ...
... free swim classes for Gainesville children age 6 months ... Sebastian Ferrero Foundation is partnering with ... Center to provide over 300 local children the opportunity ... Swim for Safety event is part of an ongoing initiative coordinated ...
... by Prof. Nils Brose of the Max Planck Institute for ... of the European Union, to study the role of synaptic ... teams is headed by Prof. Kobi Rosenblum of the University ... awarded a grant of 600,000 Euro. The topic of the ...
... 19 A new Deloitte study profiling the ... Canada and Germany was released today at the ... findings of the report, available at ... comparative effectiveness has the potential to improve care ...
... Health Equipment business sold in two separate transactions-- ... additional working capital to fund DailyMed(TM) growthINDIANAPOLIS, May ... KAD ), a leading provider of home ... Arcadia HealthCare(SM) brand, today announced the sale of ...
Cached Medicine News:Health News:VA Needs Legislative Push to Inform Veterans of Health Issues Connected to Military Service 2Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 2Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 3Health News:Quest Diagnostics Commences Cash Tender Offer for Up to $200 Million Aggregate Principal Amount of Certain of its Outstanding Notes 4Health News:Sebastian Ferrero Foundation Continues Support of Community Child Safety Programs 2Health News:Deloitte Comparative Effectiveness Study Evaluates Potential Savings Opportunities for U.S. Health Care System 2Health News:Deloitte Comparative Effectiveness Study Evaluates Potential Savings Opportunities for U.S. Health Care System 3Health News:Deloitte Comparative Effectiveness Study Evaluates Potential Savings Opportunities for U.S. Health Care System 4Health News:Deloitte Comparative Effectiveness Study Evaluates Potential Savings Opportunities for U.S. Health Care System 5Health News:Arcadia Resources Announces Sale of Non-Strategic Businesses 2Health News:Arcadia Resources Announces Sale of Non-Strategic Businesses 3Health News:Arcadia Resources Announces Sale of Non-Strategic Businesses 4
(Date:9/18/2014)... BCC Research report discusses the medical device technologies in terms ... and opportunities for different devices and regions. It includes forecasts ... the report focuses on technological trends in recent years in ... and Japan . Use ... device technologies market. - Analyze market structure, including segments and ...
(Date:9/18/2014)... , Sept. 18, 2014   Fruit Street Health ... an initial seed round of funding. ... led by a series of individual investors, the majority ... participated in the initial round are; Houston Cardiology ... Center Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)...  ADM Tronics Unlimited, Inc. (OTCQB: ADMT) has ... corporate Advisory Board for business development. ... Medical School and Visiting Professor at the University ... degree in Electronics Engineering and his Ph.D. in ... After spending a year as a visiting researcher ...
Breaking Medicine Technology:Medical Devices: Technologies and Global Markets 2Medical Devices: Technologies and Global Markets 3Medical Devices: Technologies and Global Markets 4Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3
... KONG, Dec. 21, 2011 /PRNewswire-Asia-FirstCall/ -- Golden Meditech ... 801.HK; 910801.TW), China,s leading integrated healthcare enterprise, today announced ... shares in December 2011, equivalent to 0.49% of the ... of HK$0.84 per share.Mr. KAM Yuen, Chairman and Chief ...
...  BioDelivery Sciences International, Inc. (Nasdaq: ... study, BNX-102, assessing the pharmacokinetics of its ...  The results confirm the final formulation and ... the pivotal comparative pharmacokinetic study versus Suboxone.  ...
Cached Medicine Technology:Golden Meditech Repurchases Shares 2BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study 2BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study 3BioDelivery Sciences Announces Confirmation of Final Formulation of BEMA Buprenorphine/Naloxone Based on Positive BNX-102 Study 4
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: